» Articles » PMID: 7568169

Signaling by ABL Oncogenes Through Cyclin D1

Overview
Specialty Science
Date 1995 Oct 10
PMID 7568169
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Oncogenic signals induce cellular proliferation by deregulating the cell division cycle. Cyclin D1, a regulator of G1-phase progression, acts synergistically with ABL oncogenes in transforming fibroblasts and hematopoietic cells in culture. Synergy with v-Abl depended on a motif in cyclin D1 that mediates its binding to the retinoblastoma protein, suggesting that ABL oncogenes in part mediate their mitogenic effects via a retinoblastoma protein-dependent pathway. Overexpression of cyclin D1, but not cyclin E, rescued a signaling-defective src-homology 2 (SH2) domain mutant of BCR-ABL for transformation of cells in culture and malignant tumor formation in vivo. These results demonstrate that cyclin D1 can provide essential signals for malignant transformation in concert with an activated tyrosine kinase.

Citing Articles

Repositioning antispasmodic drug Papaverine for the treatment of chronic myeloid leukemia.

Parcha P, Sarvagalla S, Ashok C, Sudharshan S, Dyavaiah M, Coumar M Pharmacol Rep. 2021; 73(2):615-628.

PMID: 33389727 DOI: 10.1007/s43440-020-00196-x.


BCR-ABL induces tyrosine phosphorylation of YAP leading to expression of Survivin and Cyclin D1 in chronic myeloid leukemia cells.

Moriyama K, Hori T Int J Hematol. 2019; 110(5):591-598.

PMID: 31428968 DOI: 10.1007/s12185-019-02726-7.


Synchronous Occurrence of Chronic Myeloid Leukemia and Mantle Cell Lymphoma.

Pathak P, Li Y, Gray B, May Jr W, Markham M Case Rep Hematol. 2017; 2017:7815095.

PMID: 28270940 PMC: 5320374. DOI: 10.1155/2017/7815095.


Plasmacytomagenesis in Eμ-v-abl transgenic mice is accelerated when apoptosis is restrained.

Vandenberg C, Waring P, Strasser A, Cory S Blood. 2014; 124(7):1099-109.

PMID: 24986687 PMC: 4133484. DOI: 10.1182/blood-2014-04-570770.


Downregulation of miR-31, miR-155, and miR-564 in chronic myeloid leukemia cells.

Rokah O, Granot G, Ovcharenko A, Modai S, Pasmanik-Chor M, Toren A PLoS One. 2012; 7(4):e35501.

PMID: 22511990 PMC: 3325224. DOI: 10.1371/journal.pone.0035501.


References
1.
Koff A, Giordano A, Desai D, Yamashita K, Harper J, Elledge S . Formation and activation of a cyclin E-cdk2 complex during the G1 phase of the human cell cycle. Science. 1992; 257(5077):1689-94. DOI: 10.1126/science.1388288. View

2.
Lovec H, Grzeschiczek A, Kowalski M, Moroy T . Cyclin D1/bcl-1 cooperates with myc genes in the generation of B-cell lymphoma in transgenic mice. EMBO J. 1994; 13(15):3487-95. PMC: 395252. DOI: 10.1002/j.1460-2075.1994.tb06655.x. View

3.
Matsushime H, Ewen M, Strom D, Kato J, Hanks S, Roussel M . Identification and properties of an atypical catalytic subunit (p34PSK-J3/cdk4) for mammalian D type G1 cyclins. Cell. 1992; 71(2):323-34. DOI: 10.1016/0092-8674(92)90360-o. View

4.
Ajchenbaum F, Ando K, DeCaprio J, Griffin J . Independent regulation of human D-type cyclin gene expression during G1 phase in primary human T lymphocytes. J Biol Chem. 1993; 268(6):4113-9. View

5.
Kato J, Matsushime H, Hiebert S, Ewen M, Sherr C . Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4. Genes Dev. 1993; 7(3):331-42. DOI: 10.1101/gad.7.3.331. View